Monthly Archives: January 2024

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 125mg/5ml oral suspension are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP053 Clarithromycin 125mg/5ml oral suspension expires at 23.59pm on Friday 12 January 2024. After this date, any prescriptions for Clarithromycin 125mg/5ml oral suspension [...]

The post Expiry of SSP053 Clarithromycin 125mg/5ml oral suspension appeared first on Community Pharmacy England.

Community Pharmacy England will be hosting a webinar on Drug Tariff Category M and retained margin on Tuesday 23rd January at 7pm. While changes to Category M prices are intended to ensure delivery of the agreed retained margin of £800m to the community pharmacy sector, the system is complex and the impact on individual pharmacies [...]

The post Book now for our Category M webinar appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Tegretol® (carbamazepine) 200mg and 400mg prolonged release tablets. MSN/2024/004 Tier 2 – medium impact Date of issue: 10th January 2024 Tegretol® (carbamazepine) 200mg prolonged release (PR) tablets are out of stock until mid-January 2024. Once back in stock, supplies can support [...]

The post Medicine Supply Notification: Tegretol® (carbamazepine) 200mg and 400mg prolonged release tablets appeared first on Community Pharmacy England.

Pharmacy owners and their teams can now watch an on-demand recording of Community Pharmacy England’s webinar on the re-launch of the Hypertension Case-Finding Service. Held last week, over 400 people tuned in to watch our Hypertension Case-Finding Service webinar. The latest in our series of webinars* aimed at assisting the pharmacy sector in preparing for [...]

The post Watch our Hypertension Case-Finding Service webinar appeared first on Community Pharmacy England.

A community pharmacy in Farnborough has participated in a proof of concept evaluation that aimed to test if detection of heart valve disease (HVD) using digital auscultation by a community pharmacist could be an effective entry point to the HVD pathway towards diagnosis and treatment. The service evaluation, which was developed in Farnborough Primary Care [...]

The post Service case study: Proactive detection of HVD in community pharmacy appeared first on Community Pharmacy England.